therefore, antioxidant activity may result from its ability to bind bilirubin, homocysteine, and lipids
The maximum permissible dose of the active substance per 1 kg of body weight is: for cats 2 mg, for horses, pigs under 4 weeks, dogs 4 mg
Plant Cell Environ 37(2):488498
The FLOW trial, the first dedicated kidney outcomes trial designed specifically to evaluate a GLP-1 medicine in people with chronic kidney disease and type 2 diabetes, was stopped early because an independent monitoring committee determined that clear evidence of benefit had already emerged.[11] In clinical research, trials are rarely stopped early
When these come into contact with your skin, they cause clogged pores, acne, and a variety of other skin infections
Ajorlo, M., Abdullah, R